SCHEMBL30689383

SCHEMBL30689383

C=C(Cc1nc(-c2ccc(Oc3cccc(C(=O)NC)n3)cc2)no1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 4/20 0.41
▸ LMNA P02545 2/20 0.41
▸ ATM Q13315 1/20 0.41
▸ ACACB O00763 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ SCN9A Q15858 1/20 0.40
▸ MAPT P10636 2/20 0.39
▸ MITF O75030 1/20 0.39
▸ NCOA3 Q9Y6Q9 1/20 0.39
▸ SMPD1 P17405 2/20 0.39
▸ GSTP1 P09211 1/20 0.38
▸ PLK1 P53350 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689408 0.88 TP53 (0.39) TP53LMNAATMACACBALDH1A1
SCHEMBL30689336 0.87 LMNA (0.43) TP53LMNAATMACACBALDH1A1
SCHEMBL30689323 0.87 TP53 (0.42) TP53LMNAATMACACBALDH1A1
SCHEMBL30689392 0.85 LMNA (0.44) TP53LMNAATMACACBALDH1A1
SCHEMBL30689449 0.83 LMNA (0.44) TP53LMNAATMACACBALDH1A1
SCHEMBL30689347 0.80 IP6K1 (0.48) TP53LMNAATMACACBALDH1A1
SCHEMBL31527959 0.79 LMNA (0.42) TP53LMNAATMACACBALDH1A1
SCHEMBL30689303 0.78 TP53 (0.42) TP53LMNAATMACACBALDH1A1
SCHEMBL30689424 0.77 TP53 (0.43) TP53LMNAATMACACBMAPT
SCHEMBL31527827 0.77 TP53 (0.46) TP53LMNAATMACACBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO disclosed
Send feedback